| Literature DB >> 34926115 |
Dong Zhang1,2, Zhi Ma1,2, Hanchi Chen1,2, Weilin Ma1,2, Jiawei Zhou1,2, Qing Wang1,2, Chan Min1,2, Yuele Lu1,2, Xiaolong Chen1,2,3.
Abstract
A novel strain with antifungal activity against Sclerotinia sclerotiorum was isolated from soil, and identified as Streptomyces sp. ZJUT-IFE-354 using morphological and 16S rDNA sequence analysis. The bioactive metabolite produced by strain ZJUT-IFE-354 was identified and characterized as valinomycin by spectroscopic and chemical methods. The yield of valinomycin was 191.26 mg/L from the culture of Streptomyces sp. ZJUT-IFE-354, which was the highest yield to our knowledge. The in vitro antifungal activity of valinomycin against S. sclerotiorum was investigated as 0.056 ± 0.012 (EC50) and 0.121 ± 0.023 μg/mL (EC95), respectively, which was approximately 10.696- and 30.960-fold more active than that of carbendazim. The results from scanning electron microscopy, cell membrane permeability, and D-sorbitol and ergosterol assay indicated that valinomycin exerted the antifungal activity probably by increasing permeability of fungal cell membrane, leading to mycelial electrolyte leakage, and eventually resulting in the death of S. sclerotiorum. Thus, valinomycin may be a promising antifungal agent to control S. sclerotiorum. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-021-03055-5. © King Abdulaziz City for Science and Technology 2021.Entities:
Keywords: Antifungal activity; Antifungal mechanism; Sclerotinia sclerotiorum; Streptomyces; Valinomycin
Year: 2021 PMID: 34926115 PMCID: PMC8639877 DOI: 10.1007/s13205-021-03055-5
Source DB: PubMed Journal: 3 Biotech ISSN: 2190-5738 Impact factor: 2.406